Search Results 51-60 of 22730 for remdesivir
Cardiac Conduction Delay Associated With Remdesivir in COVID-19 Journal of Contemporary Pharmacy Practice. 2022; 69(4):13-16. Epub 2022 Dec 28. Razonable RR, ...
The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease ...
Participation in clinical trials with remdesivir or convalescent plasma is permitted provided the subject meets all other eligibility criteria. Females of ...
Dr. Caulfield's Drug Discovery, Design and Optimization for Novel Therapeutics Lab at Mayo Clinic studies how to prevent viruses from binding, entering and ...
COVID-19 pills may limit severe disease, but vaccination is still the best option. Over the past two months, data on two pills to treat COVID-19 became ...
Each agent will be evaluated as add-on therapy to the standard of care (SoC) in accordance with national or local guidelines, which may include remdesivir.
What are the symptoms of post-COVID-19 syndrome? · Fatigue · Symptoms that get worse after physical or mental effort · Fever · Lung (respiratory) symptoms, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.